Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid-free Aprepitant Regimen for CINV in Colorectal Cancer
NCT02909478Phase 3Completed
- Sponsor
- Sun Yat-sen University
- Start
- Sep 2017
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of aprepitant in chemotherapy-induced nausea and vomiting (CINV) (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Complete Response. Started Sep 2017; status: completed.
02
Drugs
aprepitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT02909478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02909478.